Microbiotica Ltd has made two appointments to its management team. Ronald Carter joins as chief medical officer and will be responsible for the clinical development of the company’s live bacterial therapeutics and biomarkers, as well as expanding its clinical operations beyond the UK. Dr Carter has served as CMO at Mologen, Indivumed and MaaTPharma. He will be joined on the management team by Tim Sharpington as chief operating officer. Mr Sharpington has held leading executive and board-level positions in pharma and biotech across the UK and US.
Microbiotica announced the appointments on 4 February 2021
Copyright 2021 Evernow Publishing Ltd.